{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:04:53Z","timestamp":1793279093444,"version":"4.5.0"},"reference-count":284,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jacc.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T20:02:20Z","timestamp":1552852940000},"page":"1376-1414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1062,"title":["2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary"],"prefix":"10.1016","volume":"74","author":[{"given":"Donna K.","family":"Arnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Buroker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Dennison","family":"Himmelfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lloyd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. William","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Miedema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr.","given":"Kim A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boback","family":"Ziaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.5888\/pcd13.160211","article-title":"Heart disease and cancer deaths\u2014trends and projections in the United States, 1969-2020","volume":"13","author":"Weir","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jacc.2019.03.009_bib2","first-page":"3","article-title":"CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors\u2014United States, 2005-2013","volume":"63","author":"Johnson","year":"2014","journal-title":"MMWR Suppl"},{"key":"10.1016\/j.jacc.2019.03.009_bib3","first-page":"1","article-title":"Mortality in the United States, 2015","author":"Xu","year":"2016","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jacc.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.290.7.891","article-title":"Major risk factors as antecedents of fatal and nonfatal coronary heart disease events","volume":"290","author":"Greenland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s Strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2018.07.007","article-title":"Cardiovascular health promotion: an issue that can no longer wait","volume":"72","author":"Turco","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mayocp.2016.01.019","article-title":"A\u00a0systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations","volume":"91","author":"Younus","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.03.009_bib8","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib9","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, et\u00a0al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print].","DOI":"10.1161\/CIR.0000000000000624"},{"key":"10.1016\/j.jacc.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib11","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archinternmed.2009.316","article-title":"The potency of team-based care interventions for hypertension: a meta-analysis","volume":"169","author":"Carter","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","article-title":"US pharmacists\u2019 effect as team members on patient care: systematic review and meta-analyses","volume":"48","author":"Chisholm-Burns","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/1060028017711454","article-title":"Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis","volume":"51","author":"Fazel","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2019.03.009_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/M17-1805","article-title":"Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis","volume":"168","author":"Mills","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amepre.2014.03.004","article-title":"Team-based care and improved blood pressure control: a community guide systematic review","volume":"47","author":"Proia","year":"2014","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jch.12077","article-title":"Physician-pharmacist co-management and 24-hour blood pressure control","volume":"15","author":"Chen","year":"2013","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clinthera.2014.06.030","article-title":"Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial","volume":"36","author":"Hirsch","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacc.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s11606-008-0791-x","article-title":"A\u00a0randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension","volume":"23","author":"Hunt","year":"2008","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/phar.1727","article-title":"Evaluation of pharmacists\u2019 work in a physician-pharmacist collaborative model for the management of hypertension","volume":"36","author":"Isetts","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2019.03.009_bib20","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/archinte.168.21.2355","article-title":"A\u00a0randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)","volume":"168","author":"McLean","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/HYPERTENSIONAHA.115.06023","article-title":"Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control","volume":"66","author":"Polgreen","year":"2015","journal-title":"Hypertension"},{"issue":"suppl 4","key":"10.1016\/j.jacc.2019.03.009_bib22","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.1007\/s11606-010-1390-1","article-title":"Using the Teamlet Model to improve chronic care in an academic primary care practice","volume":"25","author":"Chen","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2150131916645580","article-title":"Team-based hypertension management to improve blood pressure control","volume":"7","author":"Kravetz","year":"2016","journal-title":"J\u00a0Prim Care Community Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/dc17-0426","article-title":"Five-year effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses\u2014a population-based and propensity-matched cohort study","volume":"41","author":"Wan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib25","doi-asserted-by":"crossref","first-page":"e009116","DOI":"10.1136\/bmjopen-2015-009116","article-title":"Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial","volume":"5","author":"Buhse","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2019.03.009_bib26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11606-011-1794-6","article-title":"A\u00a0randomized trial to improve patient-centered care and hypertension control in underserved primary care patients","volume":"26","author":"Cooper","year":"2011","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12913-016-1603-3","article-title":"Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program","volume":"16","author":"Olomu","year":"2016","journal-title":"BMC Health S24erv Res"},{"key":"10.1016\/j.jacc.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1370\/afm.1161","article-title":"Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study","volume":"8","author":"Parchman","year":"2010","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIR.0000000000000228","article-title":"Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Havranek","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib30","doi-asserted-by":"crossref","first-page":"e0195774","DOI":"10.1371\/journal.pone.0195774","article-title":"Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education\u2014a rapid review","volume":"13","author":"Vilhelmsson","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jech-2016-207890","article-title":"Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis","volume":"71","author":"Backholer","year":"2017","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/HJR.0b013e328339cc99","article-title":"Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review","volume":"17","author":"Beauchamp","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2019.03.009_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/2047487317705916","article-title":"Effects of education and income on cardiovascular outcomes: a systematic review and meta-analysis","volume":"24","author":"Khaing","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2458-5-7","article-title":"Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review","volume":"5","author":"Pollitt","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib36","first-page":"598","volume":"38","author":"DeFilippis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.03.009_bib37","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/CIR.0000000000000579","article-title":"Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association","volume":"138","author":"Magnani","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib38","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/archinternmed.2010.314","article-title":"Body size misperception: a novel determinant in the obesity epidemic","volume":"170","author":"Powell","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jpag.2003.09.007","article-title":"Different shapes in different cultures: body dissatisfaction, overweight, and obesity in African-American and caucasian females","volume":"16","author":"Padgett","year":"2003","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jacc.2019.03.009_bib40","unstructured":"U.S. Department of Health and Human Services. Healthy People 2020. Washington, DC: 2010. Available at: https:\/\/www.healthypeople.gov. Accessed January 3,\u00a02019."},{"key":"10.1016\/j.jacc.2019.03.009_bib41","doi-asserted-by":"crossref","first-page":"e0166846","DOI":"10.1371\/journal.pone.0166846","article-title":"Built environment, selected risk factors and major cardiovascular disease outcomes: a systematic review","volume":"11","author":"Malambo","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.03.009_bib42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1186\/s12889-018-5870-2","article-title":"Built and natural environment planning principles for promoting health: an umbrella review","volume":"18","author":"Bird","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/aje\/kwv296","article-title":"Neighborhood environments and incident hypertension in the Multi-Ethnic Study of Atherosclerosis","volume":"183","author":"Kaiser","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib44","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/oby.2005.251","article-title":"Achieving healthy weight in African-American communities: research perspectives and priorities","volume":"13","author":"Kumanyika","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.jacc.2019.03.009_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/09540261.2014.911148","article-title":"Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?","volume":"26","author":"Grandner","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jacc.2019.03.009_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.socscimed.2012.05.002","article-title":"Sociodemographic and cultural determinants of sleep deficiency: implications for cardiometabolic disease risk","volume":"79","author":"Knutson","year":"2013","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib47","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(04)16202-8","article-title":"Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes","volume":"363","author":"Ismail","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pec.2008.08.026","article-title":"An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status","volume":"75","author":"Alam","year":"2009","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacc.2019.03.009_bib49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11606-014-2855-4","article-title":"Effectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regression","volume":"29","author":"Bolen","year":"2014","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/a0040388","article-title":"Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice","volume":"71","author":"Gonzalez","year":"2016","journal-title":"Am Psychol"},{"key":"10.1016\/j.jacc.2019.03.009_bib51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chest.2017.01.026","article-title":"Insomnia and risk of cardiovascular disease","volume":"152","author":"Javaheri","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2019.03.009_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ypmed.2014.12.008","article-title":"Social engagement and chronic disease risk behaviors: the Multi-Ethnic Study of Atherosclerosis","volume":"71","author":"Samuel","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41533-016-0004-8","article-title":"National guidelines for smoking cessation in primary care: a literature review and evidence analysis","volume":"27","author":"Verbiest","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib54","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of\u00a0Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib56","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC Health Promotion Series","volume":"72","author":"Ference","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib57","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, et\u00a0al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print].","DOI":"10.1161\/CIR.0000000000000624"},{"key":"10.1016\/j.jacc.2019.03.009_bib58","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2018.01.014","article-title":"Basic vs more complex definitions of family history in the prediction of coronary heart disease: the Multi-Ethnic Study of Atherosclerosis","volume":"93","author":"Patel","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.03.009_bib59","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rinc\u00f3n","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2019.03.009_bib60","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib61","doi-asserted-by":"crossref","first-page":"e003497","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2019.03.009_bib62","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","article-title":"Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women","volume":"135","author":"Tanz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib63","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/gme.0b013e3182517bd0","article-title":"Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis","volume":"19","author":"Wellons","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jacc.2019.03.009_bib64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.118.033990","article-title":"Erectile dysfunction as an independent predictor of future cardiovascular events","volume":"138","author":"Uddin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib65","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib66","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib67","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/M14-1281","article-title":"An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort","volume":"162","author":"DeFilippis","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2016.03.022","article-title":"CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA\/ACC primary prevention guidelines","volume":"10","author":"Mahabadi","year":"2017","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2019.03.009_bib70","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.03.009_bib71","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","volume":"66","author":"McClelland","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib72","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2016.17020","article-title":"Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis","volume":"316","author":"Kavousi","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2016.5493","article-title":"Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death","volume":"2","author":"Carr","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2016.05.084","article-title":"A\u00a0simple disease-guided approach to personalize ACC\/AHA-recommended statin allocation in elderly people: the BioImage Study","volume":"68","author":"Mortensen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","article-title":"Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"133","author":"Blaha","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib76","doi-asserted-by":"crossref","first-page":"e003186","DOI":"10.1161\/CIRCIMAGING.115.003186","article-title":"Coronary artery calcium improves risk assessment in adults with a family history of premature coronary heart disease: results from the Multi-Ethnic Study of Atherosclerosis","volume":"8","author":"Patel","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2019.03.009_bib77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.2015.7515","article-title":"Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events","volume":"314","author":"Pursnani","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib78","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jcmg.2015.01.025","article-title":"A\u00a015-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of\u00a09,715 individuals","volume":"8","author":"Valenti","year":"2015","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2019.03.009_bib79","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamacardio.2017.2498","article-title":"Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies","volume":"2","author":"Yano","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib80","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","article-title":"Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment","volume":"67","author":"Yeboah","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib83","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2017.01.030","article-title":"The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2017","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2019.03.009_bib84","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2017.0944","article-title":"Subclinical atherosclerosis, statin eligibility, and outcomes in African American individuals: the Jackson Heart Study","volume":"2","author":"Shah","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib87","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2012.14312","article-title":"Lifetime risk and years lived free of total cardiovascular disease","volume":"308","author":"Wilkins","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib88","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib89","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"66","author":"Nasir","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib90","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib91","first-page":"624","article-title":"Healthy plant-based diets are associated with lower risk of all-cause mortality in US adults","volume":"148","author":"Kim","year":"2018","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib92","first-page":"881","article-title":"Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults","volume":"144","author":"Reedy","year":"2014","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2017.05.047","article-title":"Healthful and unhealthful plant-based diets and the risk of coronary heart disease in US adults","volume":"70","author":"Satija","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa1613502","article-title":"Association of changes in diet quality with total and cause-specific mortality","volume":"377","author":"Sotos-Prieto","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib95","first-page":"612","article-title":"Paleolithic and Mediterranean diet pattern scores are inversely associated with all-cause and cause-specific mortality in adults","volume":"147","author":"Whalen","year":"2017","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib96","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa1307352","article-title":"Association of nut consumption with total and cause-specific mortality","volume":"369","author":"Bao","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib97","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.109.915165","article-title":"Major dietary protein sources and risk of coronary heart disease in women","volume":"122","author":"Bernstein","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamainternmed.2016.4182","article-title":"Association of animal and plant protein intake with all-cause and cause-specific mortality","volume":"176","author":"Song","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib99","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/ije\/dyy030","article-title":"Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort","volume":"47","author":"Tharrey","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2019.03.009_bib100","doi-asserted-by":"crossref","first-page":"320S","DOI":"10.3945\/ajcn.113.071431","article-title":"A\u00a0provegetarian food pattern and reduction in total mortality in the Prevenci\u00f3n con Dieta Mediterr\u00e1nea (PREDIMED) study","volume":"100","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib101","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamainternmed.2016.2417","article-title":"Association of specific dietary fats with total and cause-specific mortality","volume":"176","author":"Wang","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib102","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(17)32252-3","article-title":"Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study","volume":"390","author":"Dehghan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib104","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.2017.0947","article-title":"Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States","volume":"317","author":"Micha","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib106","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3945\/ajcn.112.049064","article-title":"Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort","volume":"97","author":"Kiage","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib107","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/EJE-16-0376","article-title":"Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes","volume":"175","author":"L\u00f6fvenborg","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2019.03.009_bib108","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamainternmed.2013.13563","article-title":"Added sugar intake and cardiovascular diseases mortality among US adults","volume":"174","author":"Yang","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib109","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1161\/CIR.0000000000000569","article-title":"Low-calorie sweetened beverages and cardiometabolic health: a science advisory from the American Heart Association","volume":"138","author":"Johnson","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib110","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/CIRCULATIONAHA.114.014421","article-title":"Southern dietary pattern is associated with hazard of acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study","volume":"132","author":"Shikany","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib111","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2468-2667(18)30135-X","article-title":"Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis","volume":"3","author":"Seidelmann","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib112","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.ejcn.1602557","article-title":"Low-carbohydrate-high-protein diet and long-term survival in a general population cohort","volume":"61","author":"Trichopoulou","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib113","doi-asserted-by":"crossref","first-page":"e55030","DOI":"10.1371\/journal.pone.0055030","article-title":"Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies","volume":"8","author":"Noto","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.03.009_bib114","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamacardio.2017.0491","article-title":"Hospital admissions for myocardial infarction and stroke before and after the trans-fatty acid restrictions in New York","volume":"2","author":"Brandt","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2009.79","article-title":"Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes","volume":"5","author":"Micha","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacc.2019.03.009_bib116","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib117","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1136\/bmj.e1389","article-title":"Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials","volume":"344","author":"Orrow","year":"2012","journal-title":"BMJ"},{"issue":"suppl","key":"10.1016\/j.jacc.2019.03.009_bib118","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.ypmed.2014.09.012","article-title":"Effectiveness of physical activity promotion interventions in primary care: a review of reviews","volume":"76","author":"Sanchez","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib119","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(16)30370-1","article-title":"Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women","volume":"388","author":"Ekelund","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjsm.2007.039974","article-title":"Walking and primary prevention: a meta-analysis of prospective cohort studies","volume":"42","author":"Hamer","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib121","doi-asserted-by":"crossref","first-page":"i3857","DOI":"10.1136\/bmj.i3857","article-title":"Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013","volume":"354","author":"Kyu","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib122","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.110.010710","article-title":"Dose response between physical activity and risk of coronary heart disease: a meta-analysis","volume":"124","author":"Sattelmair","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib123","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10654-009-9328-9","article-title":"Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis","volume":"24","author":"Zheng","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib124","doi-asserted-by":"crossref","first-page":"e002495","DOI":"10.1161\/JAHA.115.002495","article-title":"Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis","volume":"5","author":"Wahid","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.03.009_bib125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/M14-1651","article-title":"Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis","volume":"162","author":"Biswas","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib126","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2013.03.031","article-title":"Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women\u2019s Health Initiative","volume":"61","author":"Chomistek","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib127","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10654-018-0380-1","article-title":"Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis","volume":"33","author":"Patterson","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib128","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1161\/CIR.0000000000000440","article-title":"Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association","volume":"134","author":"Young","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib129","author":"LeBlanc"},{"key":"10.1016\/j.jacc.2019.03.009_bib130","doi-asserted-by":"crossref","first-page":"j4849","DOI":"10.1136\/bmj.j4849","article-title":"Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis","volume":"359","author":"Ma","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib131","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/2047487313492631","article-title":"Coronary heart disease incidence in women by waist circumference within categories of body mass index","volume":"20","author":"Canoy","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib132","first-page":"E105","article-title":"Independent association of waist circumference with hypertension and diabetes in African American women, South Carolina, 2007-2009","volume":"9","author":"Warren","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jacc.2019.03.009_bib133","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1467-789X.2011.00879.x","article-title":"Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies","volume":"12","author":"Czernichow","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib134","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.orcp.2010.01.001","article-title":"Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women","volume":"4","author":"Flint","year":"2010","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.jacc.2019.03.009_bib135","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ejcn.2014.243","article-title":"Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis","volume":"69","author":"Huo","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib136","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/dc10-0676","article-title":"Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial","volume":"34","author":"Azadbakht","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib137","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2337\/dc06-1317","article-title":"Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis","volume":"29","author":"Snowling","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib138","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2010.1710","article-title":"Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial","volume":"304","author":"Church","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib139","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib140","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/M15-2650","article-title":"Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib141","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib142","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00125-017-4337-9","article-title":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes","volume":"60","author":"Griffin","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2019.03.009_bib143","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib144","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib146","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib147","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib148","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib149","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, et\u00a0al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print].","DOI":"10.1161\/CIR.0000000000000624"},{"key":"10.1016\/j.jacc.2019.03.009_bib150","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib151","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib152","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2019.03.009_bib153","series-title":"Statin use for the prevention of cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Report No. 14-05206-EF-2","author":"Chou","year":"2016"},{"key":"10.1016\/j.jacc.2019.03.009_bib154","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in\u00a0men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib156","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib157","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib158","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib159","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib160","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with\u00a0simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib161","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2165\/11638240-000000000-00000","article-title":"Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis","volume":"72","author":"de Vries","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2019.03.009_bib162","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of\u00a0cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of\u00a0Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib163","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-008-1076-y","article-title":"Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database","volume":"51","author":"Mulnier","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2019.03.009_bib164","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11606-015-3556-3","article-title":"Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events","volume":"31","author":"Rana","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib165","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2337\/diacare.28.5.1151","article-title":"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial\u2014lipid-lowering arm (ASCOT-LLA)","volume":"28","author":"Sever","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib166","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database","volume":"29","author":"Soedamah-Muthu","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib167","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1479164112436403","article-title":"Global cardiovascular disease risk assessment in United States adults with diabetes","volume":"9","author":"Wong","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2019.03.009_bib168","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","article-title":"Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality","volume":"68","author":"Besseling","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib169","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.116.023007","article-title":"Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes","volume":"134","author":"Nanchen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib172","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib173","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib174","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2016.05.084","article-title":"A\u00a0simple disease-guided approach to personalize ACC\/AHA-recommended statin allocation in elderly people: the BioImage Study","volume":"68","author":"Mortensen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","article-title":"Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study","volume":"64","author":"Willeit","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib176","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among\u00a0statin candidates according to American College of Cardiology\/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"66","author":"Nasir","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib177","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","article-title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.03.009_bib178","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamacardio.2017.2498","article-title":"Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies","volume":"2","author":"Yano","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib179","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","article-title":"Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic Study of Atherosclerosis","volume":"2","author":"Malik","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib180","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2014.01.060","article-title":"The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies","volume":"63","author":"Sniderman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib181","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A\u00a0meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2019.03.009_bib182","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.03.009_bib183","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib184","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(15)00508-2","article-title":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","volume":"4","author":"Huo","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2019.03.009_bib185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1479164113500798","article-title":"Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register","volume":"10","author":"Svensson","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2019.03.009_bib186","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.009","article-title":"Prospective association between diabetic retinopathy and cardiovascular disease\u2014a systematic review and meta-analysis of cohort studies","volume":"25","author":"Guo","year":"2016","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2019.03.009_bib187","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","article-title":"Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus","volume":"100","author":"Brownrigg","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2019.03.009_bib188","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejvs.2004.11.013","article-title":"Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study \u201cMen born in 1914\u201d from Malm\u00f6, Sweden","volume":"29","author":"Ogren","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2019.03.009_bib189","doi-asserted-by":"crossref","first-page":"9620513","DOI":"10.1155\/2017\/9620513","article-title":"Lower extremity peripheral arterial disease is an independent predictor of coronary heart disease and stroke risks in patients with type 2 diabetes mellitus in China","volume":"2017","author":"Pang","year":"2017","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jacc.2019.03.009_bib190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.09.060","article-title":"Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study","volume":"255","author":"Waheed","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.03.009_bib191","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib192","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.03.009_bib193","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.1992.03480090061028","article-title":"The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I","volume":"267","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib194","doi-asserted-by":"crossref","first-page":"652S","DOI":"10.1093\/ajcn\/65.2.652S","article-title":"Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group","volume":"65","author":"Whelton","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2019.03.009_bib195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.1997.00440270105009","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib196","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib197","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A\u00a0clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib198","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of\u00a0the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib199","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1056\/NEJMoa1304127","article-title":"Global sodium consumption and death from cardiovascular causes","volume":"371","author":"Mozaffarian","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib200","doi-asserted-by":"crossref","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib201","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.279.11.839","article-title":"Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group","volume":"279","author":"Whelton","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib202","doi-asserted-by":"crossref","first-page":"f1326","DOI":"10.1136\/bmj.f1326","article-title":"Effect of lower sodium intake on health: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajh.2011.210","article-title":"Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review)","volume":"25","author":"Graudal","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib204","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.1997.03540440058033","article-title":"Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials","volume":"277","author":"Whelton","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib205","doi-asserted-by":"crossref","first-page":"f1378","DOI":"10.1136\/bmj.f1378","article-title":"Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.jhh.1001575","article-title":"Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials","volume":"17","author":"Geleijnse","year":"2003","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib207","series-title":"Guideline: Potassium Intake for Adults and Children","year":"2012"},{"key":"10.1016\/j.jacc.2019.03.009_bib208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MOL.0000000000000033","article-title":"Health effects of sodium and potassium in humans","volume":"25","author":"Whelton","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2019.03.009_bib209","doi-asserted-by":"crossref","first-page":"e004473","DOI":"10.1161\/JAHA.112.004473","article-title":"Exercise training for blood pressure: a systematic review and meta-analysis","volume":"2","author":"Cornelissen","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.03.009_bib210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib211","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mayocp.2013.10.030","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis","volume":"89","author":"Carlson","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.03.009_bib212","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/obr.12054","article-title":"Effects of exercise on resting blood pressure in obese children: a meta-analysis of randomized controlled trials","volume":"14","author":"Garc\u00eda-Hermoso","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib213","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.cjca.2013.02.010","article-title":"The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example","volume":"29","author":"Rossi","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib214","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S2468-2667(17)30003-8","article-title":"The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis","volume":"2","author":"Roerecke","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib215","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/hy1101.093424","article-title":"Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"38","author":"Xin","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.03.009_bib216","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1360-0443.2008.02317.x","article-title":"Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study","volume":"103","author":"Stewart","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jacc.2019.03.009_bib217","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.hjh.0000199800.72563.26","article-title":"Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials","volume":"24","author":"Dickinson","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib218","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.297.6649.663","article-title":"Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption","volume":"297","author":"Wallace","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib219","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/jech.49.6.610","article-title":"Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group","volume":"49","author":"Lang","year":"1995","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.jacc.2019.03.009_bib220","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib221","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib222","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/M14-0773","article-title":"Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis","volume":"162","author":"Sundstr\u00f6m","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib223","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib224","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HJH.0b013e32834000be","article-title":"The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials","volume":"29","author":"Czernichow","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib226","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib227","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/HJH.0000000000000379","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels\u2014overview and meta-analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib228","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"Thompson","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib229","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels\u2014updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib230","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/HYPERTENSIONAHA.116.07608","article-title":"More versus less intensive blood pressure-lowering strategy: cumulative evidence and trial sequential analysis","volume":"68","author":"Verdecchia","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.03.009_bib231","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib232","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib233","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib234","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib236","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib237","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib238","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib239","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib240","first-page":"CD008277","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib241","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.03.009_bib242","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMsa1616035","article-title":"Cost-effectiveness of intensive versus standard blood-pressure control","volume":"377","author":"Bress","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib243","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/HYPERTENSIONAHA.115.06236","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: Action to Control Cardiovascular Risk in Diabetes blood pressure trial","volume":"66","author":"Soliman","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.03.009_bib244","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib245","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib246","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/vhrm.1.2.163.64086","article-title":"Treatment of high blood pressure and gain in event-free life expectancy","volume":"1","author":"Kassa\u00ef","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jacc.2019.03.009_bib247","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diabres.2012.05.002","article-title":"Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes","volume":"98","author":"van Dieren","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2019.03.009_bib248","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00004872-200309000-00026","article-title":"The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis","volume":"21","author":"Montgomery","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.03.009_bib249","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group","volume":"270","author":"Neaton","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib251","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa060838","article-title":"Feasibility of treating prehypertension with an angiotensin-receptor blocker","volume":"354","author":"Julius","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib252","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2002-36765","article-title":"Blood pressure and coronary heart disease: a review of the evidence","volume":"2","author":"Lawes","year":"2002","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib253","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/hr.2015.111","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit","volume":"39","author":"Inder","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2019.03.009_bib257","first-page":"CD000214","article-title":"Training health professionals in smoking cessation","author":"Carson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib258","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib259","first-page":"CD008286","article-title":"Combined pharmacotherapy and behavioural interventions for smoking cessation","volume":"3","author":"Stead","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2019.03.009_bib260","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","article-title":"Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review","volume":"132","author":"Pan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib261","doi-asserted-by":"crossref","first-page":"h1551","DOI":"10.1136\/bmj.h1551","article-title":"Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium","volume":"350","author":"Mons","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib262","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2015.07.011","article-title":"Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis","volume":"199","author":"Lv","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib263","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib264","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.03.009_bib265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-med-111314-033712","article-title":"The past, present, and future of nicotine addiction therapy","volume":"67","author":"Prochaska","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib267","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/M15-2113","article-title":"Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"164","author":"Guirguis-Blake","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib268","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7326\/M15-2112","article-title":"Bleeding risks with aspirin use for primary prevention in adults: a systematic review for the U.S. Preventive Services Task Force","volume":"164","author":"Whitlock","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib269","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pcad.2016.02.001","article-title":"Which aspirin dose and preparation is best for the long-term prevention of cardiovascular disease and cancer? Evidence from a systematic review and network meta-analysis","volume":"58","author":"Lotrionte","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2019.03.009_bib270","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.amjmed.2015.10.046","article-title":"Updated meta-analysis of aspirin in primary prevention of cardiovascular disease","volume":"129","author":"Raju","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib271","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib272","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.03.009_bib273","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib274","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial","volume":"312","author":"Ikeda","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib275","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib276","doi-asserted-by":"crossref","first-page":"e0160046","DOI":"10.1371\/journal.pone.0160046","article-title":"Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.03.009_bib277","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIR.0b013e3182285a81","article-title":"Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association","volume":"124","author":"Weintraub","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib278","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib279","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMsa1616035","article-title":"Cost-effectiveness of intensive versus standard blood-pressure control","volume":"377","author":"Bress","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMsa1406751","article-title":"Cost-effectiveness of hypertension therapy according to 2014 guidelines","volume":"372","author":"Moran","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib281","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.amepre.2017.06.020","article-title":"Cost-effectiveness analyses of antihypertensive medicines: a systematic review","volume":"53","author":"Park","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib282","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamacardio.2016.3517","article-title":"Cost-effectiveness of intensive blood pressure management","volume":"1","author":"Richman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib283","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCULATIONAHA.117.027067","article-title":"Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke","volume":"136","author":"Heller","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.03.009_bib284","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M14-1430","article-title":"Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States","volume":"162","author":"Odden","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCOUTCOMES.108.808469","article-title":"Statin cost-effectiveness in the United States for people at different vascular risk levels","volume":"2","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2019.03.009_bib286","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamacardio.2016.1419","article-title":"The ABCDs of lifestyle counseling","volume":"1","author":"Lehr","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.03.009_bib287","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2017.3303","volume":"318","author":"Patnode","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib288","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"LeBlanc","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.03.009_bib289","series-title":"Screening for abnormal glucose and type 2 diabetes mellitus: a systematic review to update the 2008 U.S. Preventive Services Task Force Recommendation. Report No. 13-05190-EF-1","author":"Selph","year":"2015"},{"key":"10.1016\/j.jacc.2019.03.009_bib290","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions\u00a0for tobacco cessation in adults, including pregnant women:\u00a0a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.03.009_bib291","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/M15-2113","article-title":"Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"164","author":"Guirguis-Blake","year":"2016","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2019.12.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000}},{"DOI":"10.1016\/j.jacc.2019.07.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719338768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719338768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:27:32Z","timestamp":1721064452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719338768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":284,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0735109719338768"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.03.009","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation and the American Heart Association, Inc.","name":"copyright","label":"Copyright"}]}}